CureVac NV Stock Quote CVAC - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

3.16

Bid

3.10

Ask

3.60

Volume

616,163

3.18 Day's Range 3.388

0.00 52 Week Range 0.00

Market Cap

729.724M

Previous Close

3.25

Open

3.38

Last Trade

149

3.16

(formt)

Last Trade Time

Financial Volume

$ 2,024,839

VWAP

3.2862

Average Volume (3m)

Shares Outstanding

223,841,600

Dividend Yield

PE Ratio

-2.80

Earnings Per Share (EPS)

-1.16

Revenue

61.71M

Net Profit

-260.17M

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-gen... CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.curevac.com

Headquarters

Tubingen, Deu

Founded

1970

CureVac NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CVAC. The last closing price for CureVac NV was $3.25. Over the last year, CureVac NV shares have traded in a share price range of $ 0.00 to $ 0.00.

CureVac NV currently has 223,841,600 shares outstanding. The market capitalization of CureVac NV is $729.72 million. CureVac NV has a price to earnings ratio (PE ratio) of -2.80.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 144 - Report of proposed sale of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GRDIGRIID Infrastructure Inc	$ 1.11 (98.21%)	155.61M
ZAPPZapp Electric Vehicles Group Ltd	$ 2.33 (71.32%)	91.47M
MGOLMGO Global Inc	$ 0.725 (58.16%)	160.24M
RELIReliance Global Group Inc	$ 0.61 (55.97%)	139.34M
HAOHaoxi Health Technology Ltd	$ 6.36 (38.26%)	693.04k
WHLRWheeler Real Estate Investment Trust Inc	$ 2.75 (-82.51%)	164.01k
KAVLKaival Brands Innovations Group Inc	$ 2.90 (-35.56%)	1.31M
MBIOMustang Bio Inc	$ 0.5605 (-34.07%)	38.16M
SONNSonnet BioTherapeutics Holdings Inc	$ 1.04 (-32.03%)	432.19k
NKLANikola Corporation	$ 0.3279 (-31.82%)	269.72M
NVDANVIDIA Corporation	$ 130.78 (-3.54%)	517.89M
NKLANikola Corporation	$ 0.3279 (-31.82%)	269.72M
SMXSMX Security Matters Public Company	$ 0.16 (34.45%)	177.77M
SQQQProShares UltraPro Short QQQ	$ 8.32 (2.46%)	166.91M
MGOLMGO Global Inc	$ 0.725 (58.16%)	160.24M